FDA is investigating a patient death that may be associated with the inhalation of the antibiotic colistimethate, or Coly-Mycin M. This drug is used to treat serious infections due to Gram-negative bacteria, particularly Pseudomonas aeruginosa. It ...
Lawyer Central Also Recommends These Stories: